AID Cann

Medical Cannabis Products

Health Tech & Life Sciences
Acquired by Limited 1498 on Dec, 2024
Public Tel Aviv-Yafo Founded 1993
Total raised
$37.6M
Last: PIPE 2021-07
Stage
Public
Founded
1993
Headcount
13
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

AID Cann is a vertically integrated medical cannabis company focused on the cultivation, manufacture, distribution, and creation of products and dosage forms for medical cannabis products. The company holds initial licenses for the entire supply chain, including growing, breeding, and nursery; production of medical cannabis products; research and development; and distribution.

The company produces its own cannabis by way of a partnership with Amit Farms, which is located in the south of Israel and designated for cannabis growth. The farm uses innovative agricultural technologies to grow high-quality cannabis and to develop Univos strains designed to meet specific therapeutic needs.

AID Cann manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. The plant is IMC-GMP certified and began production in Q3 2019. The company uses ethanol and CO2-based extraction technologies to manufacture a wide range of medical cannabis products. Additional technologies will be added to enable different delivery systems and dosages to meet the needs of the products in its R&D pipeline.

Funding history · 4 rounds · $37.6M total

2021-07
PIPE $3.6M
2019-07
PIPE $846K
2015-01
PIPE $3.2M
2001-10
Series D $30.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2C

Highlights

1 Patents

Tags

pharmaceuticalsdegenerative-diseasesepilepsyneurologyagtechmedical-cannabisbreeding